COVID-19: Oxford vaccine ‘less effective on South Africa variant’

(STL.News) British drugmaker AstraZeneca said its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of Covid-19, based on early data from a trial.

YouTube video provided courtesy of The Straights Times

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.